Literature DB >> 21994234

Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.

Siri Lillegraven1, Femke H M Prince, Nancy A Shadick, Vivian P Bykerk, Bing Lu, Michelle L Frits, Christine K Iannaccone, Tore K Kvien, Espen A Haavardsholm, Michael E Weinblatt, Daniel H Solomon.   

Abstract

OBJECTIVES: One goal of remission in rheumatoid arthritis (RA) is to halt joint damage. The authors assessed the progression of radiographic joint damage among RA patients in remission by the new ACR/EULAR criteria (Boolean approach) compared with remission thresholds for the simplified disease activity index (SDAI), clinical disease activity index (CDAI) and disease activity score based on 28 joints and C-reactive protein (DAS28-CRP) in an observational cohort, and evaluated the relationship between time in remission and radiographic joint damage.
METHODS: 535 RA patients underwent physical examination and laboratory assessment at baseline, 1 and 2 years. Radiographs at baseline and 2 years were scored by the van der Heijde modified Sharp score (TSS). Positive likelihood ratios for a good radiographic outcome (change in TSS <1 unit/year) were calculated for each of the remission criteria. Radiographic progression was compared between patients in remission at none, one, two and three visits by χ(2) goodness of fit statistics.
RESULTS: 20% of patients in ACR/EULAR remission at baseline had radiographic progression, 24% in SDAI remission, 19% in CDAI remission and 30% of patients in DAS28-CRP remission. The positive likelihood ratio for good radiographic outcome was 2.6 for ACR/EULAR criteria, 2.1 for SDAI, 2.8 for CDAI and.1.5 for DAS28-CRP. Reduced radiographic progression was observed for patients with an increasing number of visits in remission (p<0.003 for all criteria, χ(2) goodness of fit statistics).
CONCLUSIONS: Patients with RA in remission by any established criteria can experience radiographic progression. An increased number of visits in remission was associated with reduced radiographic damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21994234     DOI: 10.1136/ard.2011.154625

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  50 in total

Review 1.  [Physical therapy as part of a complex orthopedic rheumatology approach. Physiotherapy, cryotherapy, extracorporeal shockwave lithotripsy, local intra-articular joint injections].

Authors:  I Arnold; T Guttke
Journal:  Orthopade       Date:  2012-07       Impact factor: 1.087

2.  [Early and advanced rheumatoid arthritis. Diagnosis and state of the art therapy strategy].

Authors:  J Wollenhaupt; K Krüger
Journal:  Z Rheumatol       Date:  2012-01       Impact factor: 1.372

3.  The burden of disease in rheumatoid arthritis.

Authors:  Till Uhlig; Rikke H Moe; Tore K Kvien
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

4.  Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis.

Authors:  Hidemasa Matsuo; Akari Imamura; Madoka Shimizu; Maiko Inagaki; Yuko Tsuji; Shuichiro Nakabo; Motomu Hashimoto; Hiromu Ito; Shiro Tanaka; Tsuneyo Mimori; Yasutomo Fujii
Journal:  J Med Ultrason (2001)       Date:  2019-09-25       Impact factor: 1.314

5.  HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis.

Authors:  Kyung-Eun Lee; Sung-Eun Choi; Haimuzi Xu; Ji-Hyoun Kang; Dong-Jin Park; Shin-Seok Lee
Journal:  Rheumatol Int       Date:  2017-09-27       Impact factor: 2.631

6.  Rheumatoid arthritis quality measures and radiographic progression.

Authors:  Sonali P Desai; Chih-Chin Liu; Heather Tory; Tabatha Norton; Michelle Frits; Siri Lillegraven; Michael Weinblatt; Jonathan Coblyn; Jinoos Yazdany; Nancy Shadick; Daniel H Solomon
Journal:  Semin Arthritis Rheum       Date:  2014-01-25       Impact factor: 5.532

7.  [Early arthritis : no advantage of an early aggressive therapy in the first 2 years].

Authors:  G Zeh; J C Henes; I Kötter
Journal:  Z Rheumatol       Date:  2012-11       Impact factor: 1.372

8.  Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: a substudy.

Authors:  Veena K Ranganath; Kambiz Motamedi; Espen A Haavardsholm; Paul Maranian; David Elashoff; Fiona McQueen; Erin L Duffy; Joan M Bathon; Jeffrey R Curtis; Weiling Chen; Larry Moreland; James Louie; Sogol Amjadi; James O'Dell; Stacey S Cofield; E William St Clair; S Louis Bridges; Harold E Paulus
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-07       Impact factor: 4.794

Review 9.  Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.

Authors:  Vivian P Bykerk; Elisabeth Lie; Susan J Bartlett; Rieke Alten; Annelies Boonen; Robin Christensen; Daniel E Furst; Sarah Hewlett; Amye L Leong; Anne Lyddiatt; Lyn March; James E May; Pam Montie; Ana-Maria Orbai; Christoph Pohl; Marieke Scholte Voshaar; Thasia Woodworth; Clifton O Bingham; Ernest H Choy
Journal:  J Rheumatol       Date:  2014-03-01       Impact factor: 4.666

Review 10.  Assessing rheumatoid arthritis disease activity with ultrasound.

Authors:  Rafael Mendonça da Silva Chakr; José Alexandre Mendonça; Claiton Viegas Brenol; Ricardo Machado Xavier; João Carlos Tavares Brenol
Journal:  Clin Rheumatol       Date:  2013-05-23       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.